Entity

Time filter

Source Type

South San Francisco, CA, United States

Patent
KaloBios Pharmaceuticals | Date: 2014-10-08

The current invention provides high-affinity antibodies to the


Patent
KaloBios Pharmaceuticals | Date: 2013-02-22

The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of a patient that has Alzheimers disease or vascular dementia, or is at risk for developing Alzheimers disease. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody and pharmaceutical compositions comprising such antagonists.


Patent
KaloBios Pharmaceuticals | Date: 2012-04-30

The current invention relates to high-affinity antibodies to Granulocyte-Macrophage Colony-Stimulating Factor that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.


Patent
KaloBios Pharmaceuticals | Date: 2015-04-02

The current invention relates to high-affinity antibodies to Granulocyte-Macrophage Colony-Stimulating Factor that have reduced immunogenicity when administered to a human to treat diseases and method of using such antibodies.


Patent
KaloBios Pharmaceuticals | Date: 2015-12-14

The invention provides methods for generating human antibodies with the specificity of a reference antibody by replacement of portions of the V

Discover hidden collaborations